Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Proposed Guideline, H59AE
standard by Clinical and Laboratory Standards Institute, 03/01/2011

Laboratory Testing for the Lupus Anticoagulant; Approved Guideline, H60AE
standard by Clinical and Laboratory Standards Institute, 04/01/2014

Specifications for Immunological Testing for Infectious Diseases; Approved Guideline-Second Edition, ILA18A2E
standard by Clinical and Laboratory Standards Institute, 09/20/2001

Analytical Performance Characteristics, Quality Assurance, and Clinical Utility of Immunological Assays for Human Immunoglobulin E Antibodies of Defined Allergen Specificities, 3rd Edition, ILA20Ed3E
standard by Clinical and Laboratory Standards Institute, 10/01/2016

Clinical Evaluation of Immunoassays; Approved Guideline–Second Edition, ILA21A2E
standard by Clinical and Laboratory Standards Institute, 01/01/2008

Maternal Serum Screening; Approved Standard, Second Edition, I/LA25A2
standard by Clinical and Laboratory Standards Institute, 04/01/2011

Performance of Single Cell Immune Response Assays; Approved Guideline – Second Edition, ILA26A2E
standard by Clinical and Laboratory Standards Institute, 11/01/2013

Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline-Second Edition, ILA28A2E
standard by Clinical and Laboratory Standards Institute, 01/01/2011

Detection of HLA-Specific Alloantibody by Flow Cytometry and Solid Phase Assays, Proposed Guideline, ILA29AE
standard by Clinical and Laboratory Standards Institute, 01/01/2008

Fluorescence Calibration and Quantitative Measurement of Fluorescence Intensity; Approved Guideline, ILA24-A
standard by Clinical and Laboratory Standards Institute, 08/20/2004